Analysis of echocardiographic alterations observed in sleep apnea-hypopnea syndrome and how they are influenced by hypertension;Análisis de las alteraciones ecocardiográficas del síndrome de apneas e hipopneas del sueño y su modificación con la presencia de hipertensión arterial

Revista Espanola de Cardiologia

Volumn 61, Issue 1, 2008, Pages 49-57

  Moro López, José A ^a,c   Almenar, Luis ^a   Fernández Fabrellas, Estrella ^b   Ponce, Silvia ^b   Blanquer, Rafael ^b   Salvador, Antonio ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c NONE   (Spain)

Author keywords

Echocardiography; Hypertrophy; Sleep; Systemic hypertension

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CONTROLLED STUDY; DECELERATION; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE FILLING; HEART VENTRICLE SEPTUM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MORPHOLOGY; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME; THICKNESS; MIDDLE AGED;

ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SLEEP APNEA SYNDROMES;

EID: 41949111817     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13114957     Document Type: Article

References (42)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-5.
2. Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001;163:685-9.
3. Spanish Consensus of sleep apnea-hypopnea syndrome. Sleep Spanish Group. Arch Bronconeumol. 2005;41:51-67.
4. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283:1829-36.
5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-84.
6. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol. 2001;154:50-9.
7. Alchanatis M, Tourkohoriti G, Kosmas EN, Panoutsopoulos G, Kakouros S, Papadima K, et al. Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J. 2002;20:1239-45.
8. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens. 1990;8:941-6.
9. Shivalkar B, Van de Heyning C, Kerremans M, Rinkevich D, Verbraecken J, De Backer W, et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol. 2006;47:1433-9.
10. Alchanatis M, Paradellis G, Pini H, Tourkohoriti G, Jordanoglou J. Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration. 2000;67:367-71.
11. Laaban JP, Pascal-Sebaoun S, Bloch E, Orvoën-Frija E, Oppert JM, Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest. 2002;122:1133-8.
12. Smith R, Ronald J, Delaive K, Walld R, Manfreda J, Kryger MH. What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest. 2002;121:164-72.
13. Peker Y, Hedner J, Johansson A, Bende M. Reduced hospitalization with cardiovascular and pulmonary disease in obstructive sleep apnea patients on nasal CPAP treatment. Sleep. 1997;20:645-53.
14. Ronald J, Delaive K, Roos L, Manfreda J, Bahammam A, Kryger MH. Health care utilization in the 10 years prior to diagnosis in obstructive sleep apnea syndrome patients. Sleep. 1999;22:225-9.
15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52.
16. Dingli K, Coleman EL, Vennelle M, Finch SP, Wraith PK, Mackay TW, et al. Evaluation of a portable device for diagnosing the sleep apnoea/hypoapnoea syndrome. Eur Respir J. 2003;21:253-9.
17. Lang R. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
18. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1997;55:613-8.
19. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr. 1997;10:169-78.
20. Tei C, Dujardin KS, Hodge DO, Bailey KR, McGoon MD, Tajik AJ, et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr. 1996;9:838-47.
21. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997;157:1746-52.
22. Martínez García MA, Gómez Aldaraví R, Gil Martínez T, Soler Cataluña J, Benácer Alpera B, Román-Sánchez P. Trastornos respiratorios durante el sueño en pacientes con hipertensión arterial de difícil control. Arch Bronconeumol. 2006;42:14-20.
23. Shahar E, Withney CW, Redline S. Sleep-disordered breathing and cardiovascular disease. Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19-25.
24. Douglas T, Floras J. Sleep apnea and heart failure: Part I: Obstructive sleep apnea. Circulation. 2003;107:1671-8.
25. Terán J, Alonso ML, Cordero J, Ayuela Azcárate JM, Monserrat Canal JM. Síndrome de apneas-hipopneas durante el sueño y corazón. Rev Esp Cardiol. 2006;59:718-24.
26. Montserrat JM, Ferrer M, Hernández L, Farré R, Vilagut G, Navajas D, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome. A randomized controlled study with an optimized placebo. Am J Respir Crit Care Med. 2001;164:608-13.
27. Shamsuzzaman AS, Gersh BJ, Sommers VV. Obstructive sleep apnea complications and cardiovascualr disease. JAMA. 2003;290:1906-14.
28. Arias MA, García-Río F, Alonso-Fernández A, Sánchez AM. Síndromes de apneas-hipopneas durante el sueño e insuficiencia cardiaca. Rev Esp Cardiol. 2007;60:415-27.
29. Arias MA, García-Río F, Alonso-Fernández A, Mediano O, Martinez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressures in men. Circulation. 2005;112:375-83.
30. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002;90:1284-89.
31. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30:1527-33.
32. Otto ME, Belohlavek M, Romero-Coral A, Gami AS, Gilman G, Svatikova A, et al. Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 2007;99:1298-302.
33. Dursunoglu N, Dursunoglu D, Ozkurt S, Gur S, Ozalp G, Evyapan F. Effects of CPAP on right ventricular myocardial performance index in obstructive sleep apnea patients without hypertension. Respir Res. 2006;7:22.
34. Lind L, Andren B, Ärnlöv A. The Doppler-derived myocardial performance index is determined by both left ventricular systolic and diastolic function as well as by afterload and left ventricular mass. Echocardiography. 2005;22:211-6.
35. Oh JK, Tajik J. The return of cardiac time intervals: the phoenix is rising. J Am Coll Cardiol. 2003;42:1471-4.
36. Arias MA, García-Río F. Disfunción ventricular en el síndrome de apnea-hipopnea obstructiva durante el sueño: en búsqueda de la relevancia clínica. Rev Esp Cardiol. 2007;60:569-72.
37. Dumesnil J, Gaudreault G, Honos G, Kingma J. Use of Valsalva maneuver to unmask left ventricular diastolic function abnormalities by Doppler echocardiography in patients with coronary artery disease or systemic hypertension. Am J Cardiol. 1991;68:515-9.
38. Fischer M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J. 2003;24:320-8.
39. Dursunoglu D, Dursunoglu N, Evrengül H, Ozkurt S, Kuru O, Kiliç M, et al. Impact of obstructive sleep apnoea on left ventricular mass and global function. Eur Respir J. 2005;26:283-8.
40. Kushida CA, Littner MR, Morgenthaler T, Alessi CA, Bailey D, Coleman J Jr, et al. Practice parameters for the indications for polisomnography and related procedures: An update for 2005. Sleep. 2005;28:499-521.
41. Mulgrew AT, Fox N, Ayas NT, Ryan F. Diagnosis and initial management of obstructive sleep apnea without polysomnography. A randomized validation study. Ann Inter Med. 2007;146:157-66.
42. Suzuki M, Guilleminault C, Otsuka K, Shiomi T. Blood pressure "dipping" and "non-dipping" in obstructive sleep apnea syndrome patients. Sleep. 1996;19:382-7.